At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ABSI Absci Corporation.
Market Closed 06-26 16:00:00 EDT
10.89
+0.68
+6.66%
盘后10.98
+0.09+0.78%
19:59 EDT
High11.36Low9.96Vol13.45M
Open10.02D1 Closing10.21Amplitude13.71%
Mkt Cap1.84BTradable Cap1.74BTotal Shares169.00M
T/O145.79MT/O Rate8.41%Tradable Shares160.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Healthcare Stocks Have Become a Haven for Investors Ditching Tech
Dow Jones  ·  10:30
Healthcare Stocks Have Become a Haven for Investors Ditching Tech
Absci price target raised to $10 from $4.10 at Morgan Stanley
TIPRANKS  ·  06-25 18:50
Absci price target raised to $10 from $4.10 at Morgan Stanley
Absci (ABSI) Is Up 40.3% After Positive ABS-201 Data And Equity Raise Has The Bull Case Changed?
Simply Wall St.  ·  06-25 10:16
Absci (ABSI) Is Up 40.3% After Positive ABS-201 Data And Equity Raise Has The Bull Case Changed?
Absci's ABS-201 Phase 1 Data De-Risks Hair Loss Program Ahead of Efficacy Readout, Truist Says
MT Newswires Live  ·  06-25 03:02
Absci's ABS-201 Phase 1 Data De-Risks Hair Loss Program Ahead of Efficacy Readout, Truist Says
Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD) and AbSci (ABSI)
TIPRANKS  ·  06-25 02:40
Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD) and AbSci (ABSI)
Analysts Are Bullish on These Healthcare Stocks: Inmune Bio (INMB), AbSci (ABSI)
TIPRANKS  ·  06-25 02:30
Analysts Are Bullish on These Healthcare Stocks: Inmune Bio (INMB), AbSci (ABSI)
Absci is Maintained at Buy by BTIG
Dow Jones  ·  06-25 01:36
Absci is Maintained at Buy by BTIG
Top Midday Gainers
MT Newswires Live  ·  06-25 01:31
Top Midday Gainers
Sector Update: Healthcare Stocks Rise Pre-Bell Wednesday
MT Newswires Live  ·  06-24 21:22
Sector Update: Healthcare Stocks Rise Pre-Bell Wednesday
U.S. Stocks on the Move-take-two, Wendy's, Absci
Reuters  ·  06-24 19:38
U.S. Stocks on the Move-take-two, Wendy's, Absci
Absci Rises on Positive Hair-loss Drug Data
Reuters  ·  06-24 19:11
Absci Rises on Positive Hair-loss Drug Data
Absci Corp Shares up 14% Premarket After Co Reports Early-stage Trial Data from Its Ai-designed Hair Loss Drug
THOMSON REUTERS  ·  06-24 18:43
Absci Corp Shares up 14% Premarket After Co Reports Early-stage Trial Data from Its Ai-designed Hair Loss Drug
Absci prices 13.5M shares at $7.41 in public offering
TIPRANKS  ·  06-24 18:40
Absci prices 13.5M shares at $7.41 in public offering
Absci reports Phase 1 data from human trial of ABS-201
TIPRANKS  ·  06-24 18:35
Absci reports Phase 1 data from human trial of ABS-201
Absci Prices 13,495,277-share Follow-on Offering at $7.41 Per Share to Raise $100 Million
Reuters  ·  06-24 18:35
Absci Prices 13,495,277-share Follow-on Offering at $7.41 Per Share to Raise $100 Million
Absci Corp - Prices Underwritten Offering of 13.5 Mln Shares at $7.41 Per Share
THOMSON REUTERS  ·  06-24 18:35
Absci Corp - Prices Underwritten Offering of 13.5 Mln Shares at $7.41 Per Share
Absci Corp - Eli Lilly & Company and Others Participate in $100 Mln Absci Offering
THOMSON REUTERS  ·  06-24 18:35
Absci Corp - Eli Lilly & Company and Others Participate in $100 Mln Absci Offering
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
THOMSON REUTERS  ·  06-24 18:35
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
Absci Reports Positive Interim Phase 1 Data for Abs-201 Antibody in Headline Trial
Reuters  ·  06-24 18:30
Absci Reports Positive Interim Phase 1 Data for Abs-201 Antibody in Headline Trial
Absci Corp - Abs-201 Half-life Estimated at Least 65 Days Supports Infrequent Dosing
THOMSON REUTERS  ·  06-24 18:30
Absci Corp - Abs-201 Half-life Estimated at Least 65 Days Supports Infrequent Dosing

Introduction

Company Name.
Absci Corporation.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Issue price:
--